University Of Heidelberg Medical Center

This study tested whether a shot under the skin (subcutaneous) works as well as an intravenous (IV) infusion for the drug isatuximab in people with newly diagnosed multiple myeloma who are eligible for a stem cell transplant. All participants also received standard chemotherapy d…